Home›Ocrelizumab And Hyaluronidase›Ocrelizumab And Hyaluronidase + Mitoxantrone

Does Ocrelizumab And Hyaluronidase Interact with Mitoxantrone?

Ocrelizumab And Hyaluronidase and Mitoxantrone have a moderate drug interaction according to U.S. FDA drug labeling data. Concomitant use may increase risk of additive immunosuppressive effects due to prolonged immune effects of mitoxantrone. Consider duration and mode of action when switching to ocrelizumab. The mechanism involves additive immunosuppressive effects. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Ocrelizumab And Hyaluronidase Class
Endoglycosidase
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Ocrelizumab And Hyaluronidase and Mitoxantrone occurs because additive immunosuppressive effects. Clinically, this means concomitant use may increase risk of additive immunosuppressive effects due to prolonged immune effects of mitoxantrone. consider duration and mode of action when switching to ocrelizumab. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Ocrelizumab And Hyaluronidase and your doctor is considering prescribing Mitoxantrone (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Ocrelizumab And Hyaluronidase(Ocrevus Zunovo)+💊 Mitoxantrone(Mitoxantrone)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Endoglycosidase
Drug B class
—
Source
NLP:ocrelizumab and hyaluronidase

What this means in plain English

Concomitant use may increase risk of additive immunosuppressive effects due to prolonged immune effects of mitoxantrone. Consider duration and mode of action when switching to ocrelizumab.

What the FDA label says

"Additive immunosuppressive effects"

📖 Source: NLP:ocrelizumab and hyaluronidase

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Ocrelizumab And Hyaluronidase and Mitoxantrone against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.